296280-56-3Relevant articles and documents
Design and synthesis of naphthalenic dimers as selective MT1 melatoninergic ligands
Descamps-Fran?ois, Carole,Yous, Sa?d,Chavatte, Philippe,Audinot, Valérie,Bonnaud, Anne,Boutin, Jean A.,Delagrange, Philippe,Bennejean, Caroline,Renard, Pierre,Lesieur, Daniel
, p. 1127 - 1129 (2003)
We report the synthesis and binding properties at MT1 and MT2 receptors of the first example of agomelatine (N-[2-(7-methoxynaphth-1-yl)ethyl]acetamide) dimers in which two agomelatine moieties are linked together through their methoxy substituent by a polymethylene side chain according to the bivalent ligand approach. Some of these compounds behave as MT1-selective ligands. The most selective one (5) behaves as an antagonist.
Substituted dimeric compounds
-
, (2008/06/13)
The invention relates to compounds of formula (I): A—G1—Cy—G2—Cy—G3—B??(I) wherein: A represents NR1C(Q)R2, C(Q)NR2R3or NR1C(Q)NR2R3, B represents NR1C(Q)R2, C(Q)NR2R3, NR1C(Q)NR2R3, C(Q)OR1, NR1C(Q)OR2or NR2R3, G1and G3represent an optionally substituted alkylene chain, Cy represents a ring structure and G2 represents a chain and medicinal products containing the same which are useful in treating or in preventing melatoninergic disorders.